+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency

Serum Proteins Associated with Emphysema Progression in Severe Alpha-1 Antitrypsin Deficiency

Chronic Obstructive Pulmonary Diseases 4(3): 204-216

Computed tomography (CT) lung density is an accepted biomarker for emphysema in alpha-1 antitrypsin deficiency (AATD), although concerns for radiation exposure limit its longitudinal use. Serum proteins associated with emphysema, particularly in early disease, may provide additional pathogenic insights. We investigated whether distinct proteomic signatures characterize the presence and progression of emphysema in individuals with severe AATD and normal forced expiratory volume in 1 second (FEV1). QUANTitative lung CT UnMasking emphysema progression in AATD (QUANTUM-1) is a multicenter, prospective 3-year study of 49 adults with severe AATD and FEV1 post-bronchodilator values (Post-BD) ≥ 80% predicted. All participants received chest CT, serial spirometry, and contributed to the serum biobank. Volumetric imaging display and analysis (VIDA) software defined the baseline 15th percentile density (PD15) which was indexed to CT-derived total lung capacity (TLC). We measured 317 proteins using a multiplexed immunoassay (Myriad Discovery MAP® panel) in 31 individuals with a complete dataset. We analyzed associations between initial PD15/TLC, PD15/TLC annual decline, body mass index (BMI), and protein levels using Pearson's product moment correlation. C-reactive protein (CRP), adipocyte fatty acid-binding protein (AFBP), leptin, and tissue plasminogen activator (tPA) were found to be associated with baseline emphysema and all but leptin were associated with emphysema progression after adjustments were made for age and sex. All 4 proteins were associated with BMI after further adjustment for multiple comparisons was made. The relationship between these proteins and BMI, and further validation of these findings in replicative cohorts require additional studies.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 060240798

Download citation: RISBibTeXText

PMID: 28848932

Related references

Variable development of emphysema in alpha 1 antitrypsin deficiency serum oxidized alpha 1 antitrypsin is a marker for disease heterogeneity. American Journal of Human Genetics 43(3 Suppl.): A15, 1988

Alpha-1 antitrypsin deficiency with severe pulmonary emphysema. Internal Medicine 43(3): 223-226, 2004

Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. Respiratory Research 9: 21, 2008

Epidemiology of emphysema in subjects with severe alpha 1-antitrypsin deficiency. Danish Medical Bulletin 49(2): 145-158, 2002

Liver changes in adults with alpha-1-antitrypsin deficiency and severe emphysema. Ugeskrift for Laeger 135(46): 2515-2517, 1973

An unusual case of rapid radiological progression of bullous emphysema secondary to severe α1-antitrypsin deficiency. Bmj Case Reports 2015:, 2015

Serum elastase inhibitor deficiency and alpha 1-antitrypsin deficiency in patients with obstructive emphysema. Science 165(3894): 709-711, 1969

A comparative ultrastructural and molecular biological study on Chlamydia psittaci infection in alpha-1 antitrypsin deficiency and non-alpha-1 antitrypsin deficiency emphysema versus lung tissue of patients with hamartochondroma. Bmc Infectious Diseases 4: 38, 2004

Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiologica 38(5): 826-832, 1997

Atrophy, asthma, and emphysema in patients with severe alpha-1-antitrypsin deficiency. American Journal of Respiratory & Critical Care Medicine 156(1): 68-74, 1997

Gas exchange during exercise in patients with severe alpha-1-antitrypsin deficiency emphysema. Atemwegs- und Lungenkrankheiten 21(6): 323-324, 1995

Endobronchial coil treatment in severe emphysema patients with alpha-1 antitrypsin deficiency. International Journal of Chronic Obstructive Pulmonary Disease 13: 3645-3649, 2018

Liver function in patients with pulmonary emphysema due to severe alpha-1-antitrypsin deficiency (Pi ZZ). Digestion 57(3): 165-169, 1996

Liver function in patients with alpha 1 antitrypsin deficiency and severe pulmonary emphysema. Gastroenterology 102(4 Part 2): A907, 1992

Hereditary serum alpha 1-antitrypsin deficiency and pulmonary emphysema. Lijecnicki Vjesnik 93(8): 936-941, 1971